MiNK Therapeutics, Inc.INKT
Price (close)
$12.30
Market cap
$62.8M
P/E
—
Revenue (TTM)
—
Net income
-$11.4M
Dividend yield
—
1-year total return
-9.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What MiNK Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$16.2M | -$30.2M | -$28.0M | -$22.5M | -$10.8M | -$12.5M |
| Free cash flow | -$8.4M | -$13.1M | -$19.1M | -$15.8M | — | — |
More on INKT.
- MiNK Therapeutics, Inc. summary
- MiNK Therapeutics, Inc. financial statements
- MiNK Therapeutics, Inc. key metrics
- MiNK Therapeutics, Inc. health scores and style box
- MiNK Therapeutics, Inc. earnings
- MiNK Therapeutics, Inc. dividends
- MiNK Therapeutics, Inc. valuation
- MiNK Therapeutics, Inc. ownership and insiders
- MiNK Therapeutics, Inc. peers
Figures from MiNK Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.